GT719 Injection for Recurrent/Refractory Antibody-mediated Neurological Immune Diseases
NCT07021209
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Neurological Autoimmune Diseases
Interventions
BIOLOGICAL:
GT719 Injection
Sponsor
Grit Biotechnology
Collaborators
[object Object]